GLP-1 Drugs and Addiction: Why Ozempic Is Being Studied for Alcohol and Opioids
GLP-1 receptor agonists suppress dopamine reward pathways beyond hunger, with trials showing 50% reduction in alcohol cravings. Read what the addiction research shows for semaglutide and tirzepatide.